scholarly journals Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin

Blood ◽  
2018 ◽  
Vol 131 (8) ◽  
pp. 899-910 ◽  
Author(s):  
Sharraya Aschemeyer ◽  
Bo Qiao ◽  
Deborah Stefanova ◽  
Erika V. Valore ◽  
Albert C. Sek ◽  
...  

Key Points Analysis of mutations causing nonclassical FD defined the hepcidin-binding site in the central cavity of Fpn. Hepcidin inhibits iron export through Fpn not only by causing Fpn endocytosis, but also by occluding the transporter.

PLoS ONE ◽  
2012 ◽  
Vol 7 (11) ◽  
pp. e49436 ◽  
Author(s):  
Raphael Berges ◽  
Julien Balzeau ◽  
Masayuki Takahashi ◽  
Chantal Prevost ◽  
Joel Eyer

mBio ◽  
2018 ◽  
Vol 9 (6) ◽  
Author(s):  
Molly C. Sutherland ◽  
Nathan L. Tran ◽  
Dustin E. Tillman ◽  
Joshua M. Jarodsky ◽  
Jason Yuan ◽  
...  

ABSTRACTAlthough intracellular heme trafficking must occur for heme protein assembly, only a few heme transporters have been unequivocally discovered and nothing is known about their structure or mechanisms. Cytochromecbiogenesis in prokaryotes requires the transport of heme from inside to outside for stereospecific attachment to cytochromecvia two thioether bonds (at CXXCH). The CcsBA integral membrane protein was shown to transport and attach heme (and thus is a cytochromecsynthetase), but the structure and mechanisms underlying these two activities are poorly understood. We employed a new cysteine/heme crosslinking tool that traps endogenous heme in heme binding sites. We combined these data with a comprehensive imidazole correction approach (for heme ligand interrogation) to map heme binding sites. Results illuminate the process of heme transfer through the membrane to an external binding site (called the WWD domain). Using meta-genomic data (GREMLIN) and Rosetta modeling programs, a structural model of the transmembrane (TM) regions in CcsBA were determined. The heme mapping data were then incorporated to model the TM heme binding site (with TM-His1 and TM-His2 as ligands) and the external heme binding WWD domain (with P-His1 and P-His2 as ligands). Other periplasmic structure/function studies facilitated modeling of the full CcsBA protein as a framework for understanding the mechanisms. Mechanisms are proposed for heme transport from TM-His to WWD/P-His and subsequent stereospecific attachment of heme. A ligand exchange of the P-His1 for histidine of CXXCH at the synthetase active site is suggested.IMPORTANCEThe movement or trafficking of heme is critical for cellular functions (e.g., oxygen transport and energy production); however, intracellular heme is tightly regulated due to its inherent cytotoxicity. These factors, combined with the transient nature of transport, have resulted in a lack of direct knowledge on the mechanisms of heme binding and trafficking. Here, we used the cytochromecbiogenesis system II pathway as a model to study heme trafficking. System II is composed of two integral membrane proteins (CcsBA) which function to transport heme across the membrane and stereospecifically position it for covalent attachment to apocytochromec. We mapped two heme binding domains in CcsBA and suggest a path for heme trafficking. These data, in combination with metagenomic coevolution data, are used to determine a structural model of CcsBA, leading to increased understanding of the mechanisms for heme transport and the cytochromecsynthetase function of CcsBA.


1999 ◽  
pp. 251-257 ◽  
Author(s):  
P E L√∏nning

Recent studies have documented the biochemical and clinical efficacy of novel aromatase inhibitors. These drugs belong to one of two classes: non-steroidal and steroidal drugs, known to be different with respect to enzyme binding site and their effect on the aromatase enzyme. Several studies have now confirmed a lack of complete cross-resistance to drugs of the two classes. While some of these observations may be explained by a more potent aromatase inhibition caused by some aormatase inhibitors compared to others, this is not always the case. Such observations therefore focus on the importance of alternative mechanism of action like a differential influence on the intratumour aromatase enzyme by the different drugs. Current and future studies should aim at exploring the mechanism of cross-resistance and evaluate optimal use of different aromatase inhibitors in sequence or probably, also in concert.


1997 ◽  
Vol 272 (43) ◽  
pp. 27084-27090 ◽  
Author(s):  
Toshihide Mitamura ◽  
Toshiyuki Umata ◽  
Fumie Nakano ◽  
Yuji Shishido ◽  
Tetsuro Toyoda ◽  
...  

Blood ◽  
2014 ◽  
Vol 124 (1) ◽  
pp. 142-150 ◽  
Author(s):  
Yang Liu ◽  
Colin A. Kretz ◽  
Morgan L. Maeder ◽  
Catherine E. Richter ◽  
Philip Tsao ◽  
...  

Key Points Juvenile zebrafish tolerate widespread coagulopathy due to complete ablation of antithrombin III, but develop lethal thrombosis as adults. In vivo structure/function analysis of antithrombin III in zebrafish reveals limited roles for heparin-binding and anti-IXa/Xa activity.


Sign in / Sign up

Export Citation Format

Share Document